BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20703995)

  • 1. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.
    Kara T; Akata D; Akyol F; Karçaaltıncaba M; Özmen M
    Diagn Interv Radiol; 2011 Mar; 17(1):38-43. PubMed ID: 20703995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.
    Wu LM; Xu JR; Gu HY; Hua J; Zhu J; Chen J; Zhang W; Hu J
    Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):252-64. PubMed ID: 23313568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI.
    Kitajima K; Hartman RP; Froemming AT; Hagen CE; Takahashi N; Kawashima A
    AJR Am J Roentgenol; 2015 Oct; 205(4):807-16. PubMed ID: 26397329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
    Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
    AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings.
    Rouvière O; Valette O; Grivolat S; Colin-Pangaud C; Bouvier R; Chapelon JY; Gelet A; Lyonnet D
    Urology; 2004 May; 63(5):922-7. PubMed ID: 15134982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?
    Schmuecking M; Boltze C; Geyer H; Salz H; Schilling B; Wendt TG; Kloetzer KH; Marx C
    Int J Radiat Biol; 2009 Sep; 85(9):814-24. PubMed ID: 19701842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies.
    Rud E; Baco E; Lien D; Klotz D; Eggesbø HB
    AJR Am J Roentgenol; 2014 Mar; 202(3):W241-6. PubMed ID: 24555620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.
    Hauth E; Hohmuth H; Cozub-Poetica C; Bernand S; Beer M; Jaeger H
    Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
    Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
    Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer.
    Leibovici D; Kamat AM; Do KA; Pettaway CA; Ng CS; Evans RB; Rodriguez-Bigas M; Skibber J; Wang X; Pisters LL
    Prostate; 2005 Jan; 62(1):101-4. PubMed ID: 15389800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
    Kapustin VV
    Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.
    Moman MR; van den Berg CA; Boeken Kruger AE; Battermann JJ; Moerland MA; van der Heide UA; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):741-6. PubMed ID: 19804948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?
    Iwazawa J; Mitani T; Sassa S; Ohue S
    Diagn Interv Radiol; 2011 Sep; 17(3):243-8. PubMed ID: 20859852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
    Silverman JM; Krebs TL
    AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.